Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Tesla
TSLA
|
+$378M |
| 2 |
AT&T
T
|
+$328M |
| 3 |
Roku
ROKU
|
+$326M |
| 4 |
Qualcomm
QCOM
|
+$269M |
| 5 |
PARA
Paramount Global Class B
PARA
|
+$255M |
Top Sells
| 1 |
Baidu
BIDU
|
+$1.17B |
| 2 |
Bristol-Myers Squibb
BMY
|
+$727M |
| 3 |
Pinduoduo
PDD
|
+$599M |
| 4 |
AbbVie
ABBV
|
+$564M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$483M |
Sector Composition
| 1 | Healthcare | 19.43% |
| 2 | Technology | 17.52% |
| 3 | Communication Services | 11.2% |
| 4 | Consumer Discretionary | 10.6% |
| 5 | Consumer Staples | 10.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2951
VirTra
VTSI
$62.8M
| $442K | ﹤0.01% |
71,950
+50,508
| +236% | +$310K |
|
2952
Arts-Way Manufacturing Co
ARTW
$15.8M
| $440K | ﹤0.01% |
141,846
+66,872
| +89% | +$207K |
|
2953
Matthews International
MATW
$761M
| $440K | ﹤0.01% |
11,128
-41,355
| -79% | -$1.64M |
|
2954
Revolution Medicines
RVMD
$7.56B
| $440K | ﹤0.01% |
+9,600
| New | +$440K |
|
|
PATI
2955
DELISTED
Patriot Transportation Holding, Inc. Common Stock
PATI
| $440K | ﹤0.01% |
40,000
+25,400
| +174% | +$279K |
|
|
KLDO
2956
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
| $438K | ﹤0.01% |
+54,100
| New | +$438K |
|
|
FWP
2957
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
| $436K | ﹤0.01% |
63,700
+12,945
| +26% | +$88.6K |
|
2958
EuroDry
EDRY
$32.5M
| $435K | ﹤0.01% |
49,700
+36,700
| +282% | +$321K |
|
2959
Hoth Therapeutics
HOTH
$21.3M
| $435K | ﹤0.01% |
8,840
+2,552
| +41% | +$126K |
|
2960
Nova Lifestyle
NVFY
$66.5M
| $435K | ﹤0.01% |
26,874
+14,630
| +119% | +$237K |
|
2961
Vanguard Industrials ETF
VIS
$6.11B
| $435K | ﹤0.01% |
+2,300
| New | +$435K |
|
2962
Pro-Dex
PDEX
$116M
| $433K | ﹤0.01% |
16,060
-34,600
| -68% | -$933K |
|
2963
TELA Bio
TELA
$62.2M
| $432K | ﹤0.01% |
+29,000
| New | +$432K |
|
|
CFB
2964
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
| $432K | ﹤0.01% |
31,308
+12,800
| +69% | +$177K |
|
2965
Invesco S&P 500 Equal Weight Technology ETF
RSPT
$3.79B
| $432K | ﹤0.01% |
16,000
+3,000
| +23% | +$81K |
|
2966
First Mid Bancshares
FMBH
$954M
| $431K | ﹤0.01% |
9,800
-34,912
| -78% | -$1.54M |
|
|
FRES
2967
DELISTED
Fresh2 Group Limited American Depositary Shares
FRES
| $431K | ﹤0.01% |
360
+287
| +393% | +$344K |
|
2968
HF Foods Group
HFFG
$171M
| $429K | ﹤0.01% |
59,400
-38,300
| -39% | -$277K |
|
|
MFNC
2969
DELISTED
Mackinac Financial Corporation
MFNC
| $429K | ﹤0.01% |
30,568
+13,008
| +74% | +$183K |
|
|
XIN
2970
DELISTED
Xinyuan Real Estate
XIN
| $428K | ﹤0.01% |
15,220
-2,480
| -14% | -$69.7K |
|
2971
China Pharma Holdings
CPHI
$5.97M
| $426K | ﹤0.01% |
1,015
-573
| -36% | -$240K |
|
2972
iShares MSCI Canada ETF
EWC
$3.25B
| $426K | ﹤0.01% |
12,500
-69,400
| -85% | -$2.37M |
|
|
EBTC
2973
DELISTED
Enterprise Bancorp
EBTC
| $424K | ﹤0.01% |
13,048
-16,500
| -56% | -$536K |
|
2974
Phathom Pharmaceuticals
PHAT
$874M
| $424K | ﹤0.01% |
+11,300
| New | +$424K |
|
2975
Plexus
PLXS
$3.71B
| $422K | ﹤0.01% |
4,593
-42,000
| -90% | -$3.86M |
|